Question 1

Does UBS Group own VKTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Group holds 936,055 shares of VKTX (Viking Therapeutics), worth $36.5M.

Question 2

How many shares of VKTX does UBS Group own?

Accepted Answer

As of its Q2 2026 13F, UBS Group holds 936,055 shares of VKTX (Viking Therapeutics).

Question 3

What is UBS Group's VKTX position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Group's VKTX position is worth $36.5M.

Question 4

Is UBS Group buying or selling VKTX?

Accepted Answer

In Q2 2026, UBS Group reduced its VKTX position by 411,417 shares (-30.5%).

Question 5

When did UBS Group first buy VKTX?

Accepted Answer

UBS Group already held VKTX in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	936,055	-30.5%	$36.5M	0.0%	$39.01	0
2026-Q1	Increased	1.3M	+44.1%	$43.8M	0.0%	$32.54	39
2025-Q4	Decreased	934,925	-30.4%	$32.9M	0.0%	$35.18	0
2025-Q3	Increased	1.3M	+41.1%	$35.3M	0.0%	$26.28	39
2025-Q2	Increased	951,527	+59.5%	$25.2M	0.0%	$26.50	41
2025-Q1	Decreased	596,660	-3.5%	$14.4M	0.0%	$24.15	0
2024-Q4	Increased	618,148	+87.9%	$24.9M	0.0%	$40.24	45
2024-Q3	Decreased	328,959	-8.5%	$20.8M	0.0%	$63.31	0